These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3664935)

  • 41. The effects of verapamil and nimodipine on bupivacaine-induced cardiotoxicity in rats: an in vivo and in vitro study.
    Adsan H; Tulunay M; Onaran O
    Anesth Analg; 1998 Apr; 86(4):818-24. PubMed ID: 9539608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The disposition of the new anthracycline antibiotic, menogarol, in mice.
    Dodion P; Chang BK; Egorin MJ; Olman EA; Engisch KL; Bachur NR
    Drug Metab Dispos; 1984; 12(3):365-70. PubMed ID: 6145565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
    Bellott R; Auvrignon A; Leblanc T; Pérel Y; Gandemer V; Bertrand Y; Méchinaud F; Bellenger P; Vernois J; Leverger G; Baruchel A; Robert J
    Cancer Chemother Pharmacol; 2001; 47(1):15-21. PubMed ID: 11221955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes.
    Shimizu M; Uno T; Yasui-Furukori N; Sugawara K; Tateishi T
    Eur J Clin Pharmacol; 2006 Aug; 62(8):597-603. PubMed ID: 16783561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATP-dependent uptake of anti-neoplastic agents by acidic organelles.
    Moriyama Y; Manabe T; Yoshimori T; Tashiro Y; Futai M
    J Biochem; 1994 Feb; 115(2):213-8. PubMed ID: 8206870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2008 Sep; 31(9):1200-4. PubMed ID: 18806964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue.
    Mankhetkorn S; Teodori E; Garnier-Suillerot A
    Chem Biol Interact; 1999 Jul; 121(2):125-40. PubMed ID: 10418960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma and tissue levels of digoxin in the rat following pretreatment with verapamil.
    Weinhouse E; Kaplanski J; Genchik G
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):469-72. PubMed ID: 3992024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of verapamil on the pharmacokinetics of paclitaxel in rats.
    Choi JS; Li X
    Eur J Pharm Sci; 2005 Jan; 24(1):95-100. PubMed ID: 15626582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chylomicron and VLDL metabolism in daunomycin-induced nephrotic rats].
    Gomikawa S; Hiraoka K; Yamanashi T; Mori H; Fujita Y; Takamitsu Y
    Nihon Jinzo Gakkai Shi; 1995 Jul; 37(7):366-72. PubMed ID: 7637207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
    Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of daunomycin on platelets in vitro.
    Whaun JM; Clarke HD
    Arch Int Pharmacodyn Ther; 1989; 300():292-304. PubMed ID: 2619425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.
    Tsukada Y; Hurwitz E; Kashi R; Sela M; Hibi N; Hara A; Hirai H
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7896-9. PubMed ID: 6185954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
    Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.
    Wiedemann P; Sorgente N; Bekhor C; Patterson R; Tran T; Ryan SJ
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):719-25. PubMed ID: 3997421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.
    Wedge SR; Duncan R; Kopeckova P
    Br J Cancer; 1991 Apr; 63(4):546-9. PubMed ID: 1827030
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
    Esser P; Tervooren D; Heimann K; Kociok N; Bartz-Schmidt KU; Walter P; Weller M
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):164-70. PubMed ID: 9430558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells.
    Nooter K; van den Engh G; Sonneveld P
    Cancer Res; 1983 Nov; 43(11):5126-30. PubMed ID: 6616450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.